Bis-diphosphoinositol tetrakisphosphate ([PP]
Introduction
Organisms from across the phylogenetic spectrum synthesize an assortment of phosphorylated inositol derivatives. Although this family of compounds all share the cyclohexanehexol moiety, they provide the cell with a functionally diverse range of molecules. Their versatility as intracellular signals is particularly remarkable; different sub-groups of inositol-based compounds each have specialized roles in some quite different signal transduction processes (Berridge and Irvine, 1989; Kapeller and Cantley, 1994; Shears, 1997) . In this report, we provide a new focus for studies in this field of research, by demonstrating a specific receptor-dependent regulation of the turnover of bis-diphosphoinositol tetrakisphosphate ([PP] 2 -InsP 4 ).
[PP] 2 -InsP 4 is a diphosphorylated polyphosphate, the synthesis and metabolism of which is regulated by two coupled kinase/phosphatase substrate cycles (Figure 1 ).
[PP] 2 -InsP 4 is formed by an ATP-dependent PP-InsP 5 kinase (Shears et al., 1995) ; PP-InsP 5 is in turn synthesized from an ATP-dependent InsP 6 kinase (Menniti et al., 1993; Stephens et al., 1993; Shears et al., 1995; Voglmaier et al., 1996) . A third diphosphate, PP-InsP 4 , is interconverted with InsP 5 in another kinase/phosphatase substrate cycle (Menniti et al., 1993) . Interest in this group of compounds has in part arisen from the substantial free energy change associated with the hydrolysis of the β-phosphate in the diphosphate groups (Stephens et al., 1993; Laussmann et al., 1997) . It has been suggested that this metabolic turnover may be utilized as a regulatory molecular switch, possibly through the transphosphorylation of one or more proteins (Voglmaier et al., 1996) ; some exciting preliminary evidence in support of the latter possibility has been obtained (Voglmaier et al., 1994) .
We previously have employed F -as a tool to measure the extent of the metabolic flux through these substrate cycles in intact cells (Menniti et al., 1993; Albert et al., 1997) . By inhibiting the β-phosphatases that attack PPInsP 4 and PP-InsP 5 (Menniti et al., 1993; Shears et al., 1995) , F -acts as a metabolic trap that causes the levels of both PP-InsP 4 and PP-InsP 5 to increase (Menniti et al., 1993) . These data indicated that, every hour, 30-50% of the entire cellular pools of InsP 5 and InsP 6 cycle through the diphosphorylated polyphosphates (Menniti et al., 1993; Albert et al., 1997) .
There was an intriguing, additional outcome of these experiments with F -. In earlier studies with the AR4-2J pancreatoma cell line, raising the concentration of F -from 0.8 to 10 mM caused levels of [PP] 2 -InsP 4 to decrease (Shears et al., 1995 (Shears et al., 1995) . We now describe the mechanism by which F -affects cellular [PP] 2 -InsP 4 metabolism in the DDT 1 MF-2 Syrian hamster vas deferens smooth muscle cell line.
Results and discussion
Diphosphorylated inositol polyphosphates in DDT 1 MF-2 cells HPLC was used to resolve the 3 H-labeled inositol phosphates (polarity ജInsP 2 ) in DDT 1 MF-2 cells ( Figure 2) ; (Albert et al., 1997) . Based on kinetic data suggesting that the InsP 6 kinase also phosphorylates InsP 5 (Menniti et al., 1993) , the diphosphate group of PP-InsP 4 is shown tentatively as also being present on the 5-carbon. In Dictyostelium, [PP] 2 -InsP 4 is the 5,6-isomer (Laussmann et al., 1997) ; the isomeric structure of the corresponding mammalian material has not yet been confirmed and so its designation in the figure must be considered as tentative.
there were three diphosphorylated compounds (PP-InsP 4 , peak v; PP-InsP 5 , peak vii; [PP] 2 -InsP 4 , peak viii), all of which have been observed previously in other mammalian cells (Menniti et al., 1993; Stephens et al., 1993; Shears et al., 1995; Albert et al., 1997 Figure 2 ), its levels were of sufficient magnitude to exceed those of all the InsP 4 isomers combined (3906 d.p.m.).
[PP] 2 -InsP 4 was eluted by 1.8-2 M P i , depending upon the age of the column. No more polar 3 H-labeled material was detected in these or any further experiments described in this study, even when [P i ] in the HPLC eluate was increased to 2.6 M.
The effects of F -upon the turnover of the diphosphorylated inositol polyphosphates Treatment of intact cells for 30 min with either 0.8 (not shown) or 10 mM NaF (Table I) (Menniti et al., 1993; Shears et al., 1995) . Thus, F -acts as a metabolic trap, exposing the ongoing phosphorylation of InsP 5 and InsP 6 .
F -also inhibits [PP] 2 -InsP 4 diphosphatase activity (Shears et al., 1995) [ 3 H]Inositol-labeled cells were quenched, extracted and analyzed by HPLC as described in Materials and methods. The identity of each peak was ascertained by reference to previous data using this HPLC system (Glennon and Shears, 1993; Shears et al., 1995) 
Is the effect of F -on [PP] 2 -InsP 4 levels caused by a decrease in ATP levels?
At a concentration of 10 mM, F -is a metabolic poison that depletes cellular ATP levels (see, for example, Okada and Brown, 1988) . Indeed, 30 min treatment of DDT 1 MF-2 cells with 10 mM F -caused ATP levels to drop by 70% (Table I) 
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This increased rate of synthesis of [PP] 2 -InsP 4 demonstrates the competence of the PP-InsP 5 kinase even at these reduced levels of ATP.
Is the effect of F -on [PP] 2 -InsP 4 levels mediated through phospholipase C?
Another consequence of adding 10 mM NaF to cells is the formation of an AlF 4 -complex that activates heterotrimeric GTP-binding proteins (Sternweis and Gilman, 1982) . This has a number of repercussions, among which is the activation of phospholipase C (PLC) (Blackmore et al., 1985 (Table I , and data not shown). We next investigated if there was any effect upon the diphosphorylated inositol phosphates when PLC activity was activated by an appropriate ligand of the cell surface receptors in DDT 1 MF-2 cells, namely, bradykinin (Sipma et al., 1995) . At a concentration of 100 nM, this agonist stimulated PLC activity, since cytoplasmic [Ca 2ϩ ] increased from 58 Ϯ 2 nM (n ϭ 11) to a peak value of 132 Ϯ 8 nM (n ϭ 10), and levels of [ 3 H]InsP 2 , [ 3 H]InsP 3 and [ 3 H]InsP 4 increased to, respectively, 128 Ϯ 6%, 128 Ϯ 12% and 294 Ϯ 32% of control levels (Table I , and data not shown). However, bradykinin did not significantly affect the levels of either [PP] 2 -InsP 4 or the other diphosphorylated inositol phosphates (Table I) .
Is the effect of F -on [PP] 2 -InsP 4 levels mediated through adenylate cyclase?
Basal levels of cAMP in DDT 1 MF-2 cells (2.1 Ϯ 0.5 pmol/mg protein, n ϭ 12) were elevated by a 30 min treatment with 10 mM F -(to 8.1 Ϯ 0.8 pmol/mg protein, n ϭ 4, PϽ0.001 unpaired t-test), due to AlF 4 --mediated activation of adenylate cyclase (Sternweis and Gilman, 1982 (Table I) . Levels of this polyphosphate also decreased~50% after application of cell-permeant Bt 2 cAMP (Table I) . Thus, we conclude that the predominant mechanism by which F -modifies [PP] 2 -InsP 4 turnover is through activation of adenylate cyclase. Three additional aspects of the data in Table I Figure  4 ). In fact, very similar dose-response curves were obtained for the two cyclic nucleotides (EC 50 for Bt 2 cAMP ϭ 14.7 μM; EC 50 for Bt 2 cGMP ϭ 7.9 μM). Second, there is a specificity to the effect of cyclic nucleotides upon [PP] 2 -InsP 4 turnover. The levels of the other inositol polyphosphates were not affected by elevations in cellular [cAMP] or [cGMP] (Table I) . Finally, the mechanisms of action of IBMX, Bt 2 cGMP and Bt 2 cAMP were not targeted at cellular ATP levels, which these agents did not affect (Table I ).
The effect of isoproterenol upon [PP] 2 -InsP 4 turnover and levels of cyclic nucleotides in intact cells
Isoproterenol was also used to elevate cAMP levels up to 16-fold in DDT 1 MF-2 cells ( Figure 5 , and see Norris et al., 1983) . The mean EC 50 value from seven experiments was 9 nM. In agreement with previous studies using other types of smooth muscle cell, including those of nonvascular origin (Jiang et al., 1992; Murthy and Makhlouf, 1995) , levels of cGMP (0.45 Ϯ 0.24 pmol/mg protein, n ϭ 4) were unaffected by 2-30 min incubation with 1 μM isoproterenol. PLC was not activated (Table I) .
Isoproterenol also caused a dose-dependent decrease in [PP] 2 -[ 3 H]InsP 4 levels ( Figure 5 ; the mean EC 50 value was 0.4 nM, n ϭ 4). This agonist-mediated effect was highly specific; incubation with isoproterenol did not lead to a drop in the levels of any other inositol polyphosphate (Table I) . A time course experiment (Figure 6 ) shows that 1 μM isoproterenol caused the levels of [PP] 2 -[ 3 H]InsP 4 to decrease 25% by 5 min. The reduction continued throughout a 60 min treatment, at which point the 71% decrease was the same degree of effect as that which was brought about by treatment with 10 mM F - (Table I) . Consistent with data showing that isoproterenol acts through β 2 -adrenergic receptors in DDT 1 MF-2 cells (Norris et al., 1983) , the agonist's action upon [PP] 2 - [ 3 H]InsP 4 turnover was unaffected when α-adrenergic receptors were blocked with 10 μM phentolamine (data not shown). The novelty of these observations is worth emphasizing; previously, the metabolism of the diphosphorylated inositol polyphosphates was not known to be agonist-regulated (Menniti et al., 1993; Shears et al., 1995) .
cAMP regulates [PP] 2 -InsP 4 turnover independently of A-kinase
We next investigated if A-kinase participated in the response of [PP] 2 -InsP 4 turnover to treatment with Bt 2 cAMP and isoproterenol. Three cell-permeant A-kinase antagonists were used: H-89 (Chijiwa et al., 1990) , HA1077 (Asano et al., 1989) and R p CPT-cAMPS (Roseboom and Klein, 1995) . In these experiments, two precautions were taken to optimize the opportunity for the antagonist to effectively block A-kinase. First, we used relatively high concentrations of the antagonists. Second, we chose slightly submaximal concentrations of agonists (3 nM isoproterenol and 300 μM Bt 2 cAMP) which induced 80% of the maximum possible depletion in [PP] 2 -InsP 4 levels. We also independently checked the efficacy of the A-kinase antagonists by measuring the degree of phosphorylation by A-kinase of cAMP response element-binding protein (CREB), using an anti-phospho-CREB antibody (Ginty et al., 1993) . Figure 7 shows the prominent increase in the phospho-CREB signal in extracts from cells treated with 3 nM isoproterenol (lane 3) compared with control cells (lane 1). All three cellpermeant antagonists of A-kinase reduced the phospho-CREB signal to levels that were either at or below basal levels ( Figure 7, lanes 4-6) . These data confirm the effectiveness of the antagonist protocols.
We found that the effect upon [PP] 2 -InsP 4 metabolism of both isoproterenol and Bt 2 cAMP was unaffected by any of the three A-kinase antagonists (Figure 8 ). The antagonists also had no effect by themselves (Figure 8 ). These data indicate that cAMP regulates [PP] 2 -InsP 4 turnover independently of A-kinase. We considered that one possible explanation for this mode of cAMP action might be the cross-activation of G-kinase (Jiang et al., 1992; Murthy and Makhlouf, 1995) . However, this seems unlikely for several reasons. First, cAMP is such a weak activator of the G-kinase (Gamm et al., 1995) that, in smooth muscle cells at least, it requires 10-100 μM isoproterenol before significant cross-activation can be detected (Jiang et al., 1992; Murthy and Makhlouf, 1995) . These concentrations are considerably higher than the EC 50 value of 0.4 nM for the agonist's effects on [PP] 2 -InsP 4 metabolism (see above). Second, the A-kinase antagonist, HA1077, is equally effective against G-kinase ( Asano et al., 1989 ), yet HA1077 also did not antagonize cyclic nucleotide-mediated changes in [PP] 2 -InsP 4 metabolism (Figure 8 ). Third, we used another G-kinase antagonist, R p -cGMPS (Butt et al., 1994) , and it also failed to reverse the decrease in [PP] 2 -InsP 4 levels brought about by either isoproterenol or by Bt 2 cAMP (Figure 8) . Finally, the conclusion that G-kinase does not participate in this response is reinforced further by the observation that R p -cGMPS failed to reverse the effect of Bt 2 cGMP upon [PP] 2 -InsP 4 turnover (Figure 8) . In other words, it seems that both cGMP and cAMP regulate the metabolism of [PP] 2 -InsP 4 independently of activating their respective kinases.
We further excluded the participation of protein phosphorylation processes in the regulation of [PP] 2 -InsP 4 turnover by blocking protein phosphatases with okadaic acid (Cohen, 1989) One well-recognized kinase-independent effect of cyclic nucleotides is to open Ca 2ϩ -permeable cation channels in the plasma membrane (Yau, 1994) . Although these ion channels were thought initially to be restricted to sensory cells, they are now known to be more widely distributed (Yau, 1994; Ding et al., 1997) . We found that cyclic nucleotide-mediated depletion in [PP] 2 -InsP 4 levels was not associated with any measurable increase in the rate of Ca 2ϩ entry, as cytoplasmic [Ca 2ϩ ] was unaffected by either 1 mM IBMX, 3 mM Bt 2 cAMP, 3 mM Bt 2 cGMP or 1 μM isoproterenol (data not shown). Moreover, we also incubated cells for 30 min in the absence of extracellular Ca 2ϩ so that no Ca 2ϩ entry could occur. In these incubations, [PP] 2 -[ 3 H]InsP 4 levels were unaffected (95 Ϯ 9% of control, n ϭ 4), and 1 μM isoproterenol still caused [PP] 2 -[ 3 H]InsP 4 levels to decrease (to 51 Ϯ 7% of control, n ϭ 3) to the same extent as in medium with the normal extracellular [Ca 2ϩ ] (to 45 Ϯ 6% of control, see Table I ).
General conclusions
Among several new conclusions to arise from this study, the most important is that the metabolism of [PP] 2 -InsP 4 is regulated by the β 2 -adrenergic agonist, isoproterenol. Our data therefore provide the first evidence that there is a close relationship between [PP] 2 -InsP 4 levels and signal transduction events. This effect of isoproterenol was mediated through cAMP but, significantly, the latter acted independently of the activation of A-kinase, or the crossactivation of G-kinase. The receptor-regulated diminution in [PP] 2 -InsP 4 levels could arise as a consequence of a decrease in the rate of PP-InsP 5 phosphorylation, and/or an increase in the rate of [PP] 2 -InsP 4 dephosphorylation. Distinguishing between these two possibilities will be an important future direction as we unravel the molecular events that underlie this new regulatory process. It is an exciting possibility that an increased rate of utilization of [PP] 2 -InsP 4 could reflect up-regulation of its proposed action as a molecular switch and/or a donor for transphosphorylation reactions (Voglmaier et al., 1994 (Voglmaier et al., , 1996 .
The model system for the current study was the nonvascular, smooth muscle cell line, DDT 1 MF-2. In these cells, F -affects [PP] 2 -InsP 4 metabolism through an elevation in cAMP levels. Since an F --mediated reduction in [PP] 2 -InsP 4 levels has also been observed in AR4-2J pancreatoma cells (Shears et al., 1995) , we can therefore anticipate a wider occurrence of these effects of cAMP upon [PP] 2 -InsP 4 turnover. Moreover, our demonstration that Bt 2 cGMP is as effective a stimulus as Bt 2 cAMP (Figure 4) suggests that physiologically relevant elevations in cellular [cGMP] [such as those induced by nitric oxide (Garthwaite and Boulton, 1995) ] will also prove to regulate [PP] 2 -InsP 4 metabolism.
The diphosphorylated polyphosphates have already attracted attention in view of their rapid interconversion in coupled substrate cycles (Figure 1) , and because of the considerable free energy change upon the hydrolysis of the β-phosphate of the diphosphate groups. It is surely the case that the cell reaps some considerable benefit from the energy it expends in order to sustain the steady-state levels of these metabolically active compounds. Now that we know this turnover is receptor-regulated, the need for further research into the biological significance of this class of compounds is stronger than ever. supplemented with 'high-glucose' (i.e. 25 mM), 2 mM glutamine and 5% fetal calf serum at 37°C in 5% CO 2 /95% humidified air. Cells were harvested and plated at a density of~200 000 cells/well (16 mm diameter, 24-well muliplates) in the DMEM-based culture medium described above, supplemented with 50 μCi/ml [ 3 H]inositol. Medium was replaced 3 and 5 days after plating. On the 7th day, cell monolayers were washed (2ϫ250 μl) and then incubated (250 μl) in [ 3 H]inositol-free HEPESbuffered Krebs solution (115 mM NaCl, 5 mM KCl, 1 mM NaH 2 PO 4 , 0.5 mM MgSO 4 , 11 mM glucose, 1.36 mM CaCl 2 , 25 mM HEPES, pH 7.4 with NaOH). Cells were maintained at 37°C for 3 h prior to the beginning of any experiments. All experimental protocols were timematched with control incubations.
Materials and methods
Experiments were quenched by rapid aspiration of the Krebs solution, followed by addition of 250 μl of ice-cold 0.6 M perchloric acid (PCA) containing 0.2 mM InsP 6 , and neutralized by the addition of 70 μl of 1 M K 2 CO 3 containing 5 mM Na 2 EDTA. After being kept at 4°C for 30 min, the perchlorate precipitate was removed by centrifugation (10 000 g, 2 min). The supernatants were finally diluted with 3 vols of 1 mM Na 2 EDTA. Similar data were also obtained when cells were quenched with a Triton-based buffer, followed by deproteinization using NENSORB columns (Shears et al., 1995) .
Samples were stored at -20°C prior to being loaded onto a 4.6ϫ125 mm Partisphere 5 μm SAX HPLC column. Inositol phosphates were eluted at 1 ml/min by the following gradient generated by mixing buffer A (1 mM Na 2 EDTA) and buffer B [buffer A plus 1.3 M (NH 4 ) 2 HPO 4 , pH 3.85 with H 3 PO 4 ; total [P i ] ϭ 2.6 M]: 0-10 min, 0% B; 10-25 min, 0-35% B; 25-105 min, 35-100% B; 105-115 min, 100% B. Fractions of 1 ml were collected, mixed with 3 vols of Monoflow 4 scintillant, and radioactivity was determined using liquid scintillation spectrometry.
Analysis of CREB phosphorylation by Western blotting
Cells were prepared in 24-well multiplates as described above, except that [ 3 H]inositol was omitted from the culture medium. Following agonist stimulation, experiments were quenched in hot Laemmli sample buffer, and cell extracts were drawn through a 27 gauge needle to reduce viscosity. Samples were run on a 10% polyacrylamide gel, and electroblotted onto a nitrocellulose membrane. After washing with phosphatebuffered saline (PBS), the membrane was incubated with an antiphospho-CREB rabbit polyclonal antibody according to the manufacturer's protocol. Antibody-antigen complexes were detected using a horseradish peroxidase-coupled anti-rabbit IgG.
Cellular [Ca 2ϩ ] measurements
DDT 1 MF-2 cells were grow on glass coverslips, washed with Krebs buffer, and equilibrated for 4 h prior to loading with 3 μM Fura-2/AM for 30 min at room temperature in the dark. Cells were then washed with Krebs buffer and fluorescence was monitored using a PTI dual wavelength spectrofluorimeter system, with excitation at 340 and 380 nm, and emission intensity was measured at 505 nm. The average free cytoplasmic [Ca 2ϩ ] was then calculated (Grynkiewicz et al., 1986) .
Other assays
The appropriate kits (see Materials) and methodologies recommended by the supplier were used to assay for cAMP, cGMP and ATP (in PCA-quenched, K 2 CO 3 -neutralized cell extracts, see above). Protein concentration was determined as described by Bradford (1976) . EC 50 values were derived using Prism (GraphPad, San Diego, CA). were purchased from NEN Life Science Products (Boston, MA). R p -cGMPS and HA1077 were purchased from RBI (Natick, MA), R p CPT-cAMPS was purchased from Biolog (La Jolla, CA). Bt 2 cAMP and Triton X-100 were purchased from Boehringer-Mannheim (Indianapolis, IN). Bradykinin, H-89, Bt 2 cGMP, okadaic acid and the ATP assay kit were purchased from Calbiochem-Novabiochem Int. (La Jolla, CA). cAMP and cGMP assay kits were purchased from Amersham Corp. (Arlington Heights, IL). Anti-phospho-CREB rabbit polyclonal antibody was supplied by Upstate Biotechnology, Waltham, MA. Fetal calf serum was purchased from Gibco (Grand Island, NY). HPLC columns were supplied by Krackler Scientific (Durham, NC). Monoflow 4 scintillant was purchased from National Diagnostics (Manville, NJ). InsP 6 was purchased from Aldrich (Milwaukee, WI). Fura-2/AM was purchased from Molecular Probes, Eugene OR. Other reagents were purchased from either Sigma or Fluka.
Materials

